Shares of Brooklyn ImmunoTherapeutics (BTX), a Brooklyn-based clinical-stage biopharmaceutical firm, have jumped almost 112% this week through Thursday and have soared 820% over the past month, likely due to buying by retail traders on a Reddit message board, similar to how meme stock GameStop soared in value earlier …
Similarly Is BTX a good stock? The consensus among 2 Wall Street analysts covering (NYSEMKT: BTX) stock is to Strong Buy BTX stock.
Who owns BTX stock? Top 10 Owners of Brooklyn Immunotherapeutics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| Morgan Stanley & Co. LLC | 1.04% | 543,461 |
| SSgA Funds Management, Inc. | 0.98% | 509,258 |
| Geode Capital Management LLC | 0.90% | 468,871 |
| Renaissance Technologies LLC | 0.57% | 297,709 |
Additionally, What kind of stock is BTX?
Key Data
| Label | Value |
|---|---|
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| 1 Year Target | $14.50 |
| Today’s High/Low | $1.83/$1.72 |
Is Brooklyn Immuno Therapeutics a buy?
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Brooklyn Immunotherapeutics is ‘Hold‘.
What happened to Brooklyn ImmunoTherapeutics? What is going on with BTX? Brooklyn ImmunoTherapeutics, Inc. (BTX) stock fell today after the company filed an 8-K form with the SEC disclosing a reduction in their workforce. The company stated that on January 3, 2022, BTX notified eight employees of their termination.
Will Brooklyn ImmunoTherapeutics stock go up? Stock Price Forecast
The 1 analysts offering 12-month price forecasts for Brooklyn Immunotherapeutics Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +448.78% increase from the last price of 1.64.
What does Brooklyn therapeutics do? Brooklyn ImmunoTherapeutics (BTX) creates transformative regenerative medicine treatments for cancer, blood disorders and monogenic diseases.
What is the future of BTX stock?
Stock Price Forecast
The 2 analysts offering 12-month price forecasts for Brooklyn Immunotherapeutics Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +368.75% increase from the last price of 1.92.
What is the future of BTX? The future of BTX is biobased and circular. BioBTX creates sustainable BTX from non-food biomass and plastic waste. BTX are vital components needed to create high performance materials, such as new plastics. As a result of sustainable BTX, plastics can become part of a circular economy.
Who owns Brooklyn immunotherapeutics?
Charles Cherington co-founded Ara in 2017, co-heads the firm alongside Troy Thacker, and is a member of the firm’s Investment Committee. He has more than 25 years of private equity experience in the industrial, energy and chemical industries in which he has executed over 50 transactions.
Is BTX short squeeze? BTX – Short Interest – Brooklyn Immunotherapeutics Inc Stock – Short Squeeze, Short Sale Volume, Borrow Rates, Fails-To-Deliver.
What is the float of BTX?
The chart has 1 X axis displaying Time. Range: 2022-03-29 09:26:07 to 2022-03-29 16:01:52.
…
Brooklyn ImmunoTherapeutics Inc.
| Volume | 406.33K |
|---|---|
| Short Interest | 2.53M (03/15/22) |
| Short Interest Change | 2.53M |
| Percent of Float | 9.96% |
Is BTX A meme stock?
Brooklyn Immunotherapeutics (BTX)
Becoming one of the hottest meme stocks out there, it soared from $5.40 at the time of the deal close (March 25), to as much as $80.67 per share.
Why did Brooklyn Therapeutics go up? “As a result of the license acquisition, Brooklyn is now poised to become a key player among companies exploring gene editing for cell therapies. This mRNA gene editing technology has the potential to be disruptive given its high efficiency and relatively low manufacturing costs.
When did Brooklyn immunotherapeutics go public? Brooklyn’s common stock is expected to begin trading as a Nasdaq-listed security on October 25, 2021 and will continue to trade under the ticker symbol “BTX.” Brooklyn’s President and CEO Howard J. Federoff, M.D., Ph.
What is NAKD stock?
Cenntro Electric Group Ltd (NAKD)
How do you buy stocks on wish? How and Where To Buy Wish Stock. If you want to buy ContextLogic Inc. stock, sign up to make an account on a trading platform and enter the requested personal information to open your brokerage account. Then you can buy the number of shares you want. The company operates under the ticker WISH.
Why is BTX stock down?
So what. The good news regarding the drop in COVID-19 cases around the country is being perceived as bad news for BioNTech, whose Comirnaty COVID-19 vaccine it developed with Pfizer has sent the company to record revenue and profits in 2021.
Is Reddit going to IPO? Reddit has filed confidentially for an IPO, the company said. Reddit could make its stock market debut in March, Bloomberg reported. The social media company could seek a valuation as high as $15 billion. Reddit will reportedly work with Morgan Stanley and Goldman Sachs for its IPO.
Is GBXI a good stock to buy?
The GBX International Group Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
What is a reverse merger deal? A reverse merger is when a private company becomes a public company by purchasing control of the public company. The shareholders of the private company usually receive large amounts of ownership in the public company and control of its board of directors.
What is Brooklyn ImmunoTherapeutics? Brooklyn ImmunoTherapeutics (BTX) creates transformative regenerative medicine treatments for cancer, blood disorders and monogenic diseases.
Will NAKD stock recover?
NAKD stock became a hit with the Reddit trading crowd and has done well to fortify its balance sheet. It’s now debt-free and has evolved into a pure-play e-commerce business. Unfortunately, there are several loopholes in its turnaround strategy, so it is unlikely things will change significantly for the company.
What will happen to NAKD stock after merger?
Under the terms of the merger, Naked shareholders will receive seven shares in the new entity for every three existing NAKD shares they own. The combined company will have a market capitalization of nearly $2 billion.
What happened NAKD stock? NAKD Stock Down on Closing of EV-Related Acquisition
Today, Naked Brand announced the closing of its acquisition of EV startup Cenntro Automotive. This deal leaves the combined company with $250 million in cash on the balance sheet, and provides a strong growth runway for those bullish on the EV sector.
